About H1N1 vaccine, H1N1vaccine production, H1N1 vaccine manufacturers

DiscoveryBioMed receives NIDDK grant for Cystic Fibrosis Corrector Ligand Drug Discovery programLucentis receives Health Canada approval to treat vision loss from DMECohera’s TissuGlu Surgical Adhesive receives CE Mark approvalZimmer receives clearance for pediatric use of Universal Clamp Spinal Fixation SystemViamet commences VT-1161 Phase 1 clinical study to treat fungal infectionsFirst Edition: September 14, 2011Celecoxib inhibits GSK3 enzyme in lung cancer cells << DiscoveryBioMed receives NIDDK grant for Cystic Fibrosis Corrector Ligand Drug Discovery program

View the Original article

Related posts:

1. Novo Nordisk announces free diabetes educational e-book series
2. UMA introduces new healthcare education and career resource center